Canis ISSN: 2398-2942

Glucosamine

Contributor(s): Vetstream Ltd

Introduction

Name

  • Glucosamine.

Class of drug

  • Nutraceutical.
  • Amino acid.
  • Chondroprotective agent.

Description

Chemical name

  • Glucosamine.

Storage requirements

  • Store in a dry place <25°C.
  • Keep container tightly closed.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • A nutritional aid in the management of degenerative joint disease.
  • Mild anti-inflammatory effect.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMed Resource.
  • Lennox C E, Lunn K F (2010 Effects of glucosamine-chondroitin sulfate supplementation on serum-fructosamine concentration in healthy dogs. JAVMA 236(2), 183-186 PubMed.
  • Sauve F, Paradis M, Refsal K R, Moreau M, Beauchamp G & Dupois J (2003) Effects of oral administration of meloxicam, carprofen and a nutraceutical on thyroid function in dogs with osteoarthritis. Can Vet J 44(6), 474-479 PubMed.
  • Adebowale A, Du J, Liang Z, Leslie J L & Eddington N D (2002) The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Dispos 23(6), 217-225 PubMed.
  • Canapp S O, McLaughlin R M, Hoskinson J J et al(2000) Scintigraphic evaluation of glucosamine HCl and chondroitin sulfate as treatment for acute synovitis in dogs. Am J Vet Res 60(12), 1552-1557 PubMed.
  • Anderson M A (1999) Oral chondroprotective agents. Part II. Evaluation of products. Comp Contin Ed Pract Vet 21(9), 861-865.
  • McIlwraith C W (1999) Should I recommend the use of oral glycosaminoglycans? Comp Contin Educ Pract Vet 21(5), 450, 457.
  • Boothe D M (1998) Nutraceuticals in veterinary medicine. Part II. Safety and efficacy.Comp  Contin Educ Pract Vet 20(1), 15-21.
  • Hulse D A (1998) Treatment methods for pain in the osteoarthritic patient. Vet Clin North Am Small Anim Pract 28(2), 361.
  • Boothe D M (1997) Nutraceuticals in veterinary medicine. Part I. Definitions and regulations. Comp Contin Educ Pract Vet 19(12), 1248-1255.
  • McNamara P S, Barr S C & Erb H N (1996) Hematologic, hemostatic and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. Am J Vet Res 57(9), 1390-1394 PubMed.

ADDED